AVP and heart failure: When it was conducted by geographical region, the predictive effect of copeptin for the all‐cause mortality of heart failure was more significant in Austrians with no significant heterogeneity (HR, 2.53; 95% CI, 1.67–3.85; P for heterogeneity = 0.698; I2 = 0.0%) than in people from other countries.